FDA Drug Application (020845) for INOMAX by MALLINCKRODT HOSP

Back to FDA Applications sponsored by MALLINCKRODT HOSP

Application Number020845
Product Number002
FormGAS;INHALATION
Dosage100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINOMAX
Active IngredientNITRIC OXIDE



Back to FDA Applications sponsored by MALLINCKRODT HOSP